Tango Therapeutics, Inc.TNGXNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
134.35%
↑ 835% above average
Average (22q)
-18.27%
Historical baseline
Range
High:134.35%
Low:-329.52%
Volatility
-2538.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 134.35% |
| Q2 2025 | 3.68% |
| Q1 2025 | -3.96% |
| Q4 2024 | -24.43% |
| Q3 2024 | -11.25% |
| Q2 2024 | 30.06% |
| Q1 2024 | -20.68% |
| Q4 2023 | -36.63% |
| Q3 2023 | -10.23% |
| Q2 2023 | 23.24% |
| Q1 2023 | 0.92% |
| Q4 2022 | -2.15% |
| Q3 2022 | -18.73% |
| Q2 2022 | 0.70% |
| Q1 2022 | -15.44% |
| Q4 2021 | -12.34% |
| Q3 2021 | -329.52% |
| Q2 2021 | 62.29% |
| Q1 2021 | -35.16% |
| Q4 2020 | 66.59% |
| Q3 2020 | -216.90% |
| Q2 2020 | -4.70% |
| Q1 2020 | 0.00% |